Announcements Trials
Browse Landscape

Phase

Phase 2 225Phase 3 86Phase 1/2 44Phase 1 19Phase NA 6Phase 2/3 5Phase 4 4Phase EARLY_PHASE1 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Pancreatic Neoplasms 1Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 7Cyclophosphamide 5Metformin 4durvalumab 3Vincristine 3Radiation 3Imiquimod 3Fluorouracil 3antitumor A 2Testosterone 2Surveys and Questionnaires 2Rituximab 2Prednisone 2Positron Emission Tomography Computed Tomography 2Oxaliplatin 2Leucovorin 2Lapatinib 2Immunoglobulin G 2HhAntag691 2Doxorubicin 2Disulfides 2Cisplatin 2Biopsy 2xentuzumab 1tremelimumab 1ribociclib 1posaconazole 1pexidartinib 1perflutren 1pazopanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Has results × Fluorouracil × Clear all
NCT02896907 2025-04-30

Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
8 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms

NCT03196180 2025-04-08

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Completed
13 enrolled 10 charts
Gynecologic

Uterine Cervical Dysplasia

NCT03515941 2020-10-12

GABLE

Baylor College of Medicine

Phase EARLY_PHASE1 Terminated
6 enrolled 10 charts
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡